| Tüüp : |
Ajaleht |
| Interneti link : |
http://www.cjhp-online.ca/index.php/cjhp/article/view/1665 |
|
| Uurimisrühmad : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
| Autor : |
Smith A.D, Rempel G, Szeitz A, Klassen T.L, Ensom M.H.H. |
| Pealkiri : |
Vancomycin 50 mg/mL Suspension in Oral Syrup: Stability in Plastic Bottles and Syringes at 2 Temperatures. |
| Publikatsioon : |
Can J Hosp Pharm ; 70,3 :247-249 2017 |
|
| Tõendite tase : |
|
| Füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
Ingredientide nimekiri
 Vancomycin hydrochloride
|
 |
 |
 |
 |
3000 mg
Vancomycine Fresenius Kabi® |
|
25°C |
 |
| 28 |
 |
|
|
|
|
|
3000 mg
Vancomycine Fresenius Kabi® |
|
4°C |
|
| 91 |
|
|
|
|
 |
|
150 mg
Vancomycine Fresenius Kabi® |
|
25°C |
|
| 28 |
|
|
|
|
|
|
150 mg
Vancomycine Fresenius Kabi® |
|
4°C |
|
| 91 |
|
|
|
|
|
